ALLOGENE THERAPEUTICS INC. - COMMON STOCK
2.4600
14-November-24 16:45:00
15 minutes delayed
Stocks
-0.2600
-9.56%
Today's range
2.4600 - 2.7527
ISIN
N/A
Source
NASDAQ
-
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
07 Nov 2024 16:02:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 10:00:00 By Nasdaq GlobeNewswire
-
05 Nov 2024 09:10:30 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in November Investor Conferences
04 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update
30 Oct 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference
30 Sep 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
08 Aug 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update
07 Aug 2024 16:02:54 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update
31 Jul 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
23 May 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
13 May 2024 16:47:42 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
13 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
06 May 2024 08:30:00 By Nasdaq GlobeNewswire
-
26 Apr 2024 08:30:00 By Nasdaq GlobeNewswire
-
Allogene Therapeutics Announces Q2 Investor Conference Participation
09 Apr 2024 08:30:00 By Nasdaq GlobeNewswire
-
14 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >